Sunifiram

Sunifiram (DM-235) is a synthetic derivative of piracetam, characterized by its cognitive-enhancing properties despite not being formally classified within the racetam family due to structural differences. As an AMPAkine compound, it acts primarily through AMPA receptors, demonstrating significant anti-amnesiac effects and potential for cognitive enhancement. This action is believed to be mediated by modulating glutamate receptors, crucial for memory and learning in the brain. Although Sunifiram shows promise in enhancing focus, concentration, and overall cognitive function, it remains largely under-researched, with its long-term safety and efficacy yet to be established. Its potency is reported to be substantially higher than traditional nootropics like piracetam, with a similarly low toxicity profile. However, due to the lack of comprehensive studies, the use of Sunifiram is approached with caution, underscoring the importance of consulting healthcare professionals before its use for cognitive enhancement​​.